Centrient welcomes the European Commissions DiversifyEU initiative and urges that antibiotics be explicitly recognized as a critical sector within it. Europe's antibiotic supply chains are highly concentrated upstream, with roughly 45% of amoxicillin API imported from Asia and near-total import dependence for key cephalosporins used in hospitals.
Centrient Pharmaceuticals
Company · Netherlands · EU Transparency Register 494574538937-86
Counts here are a floor, never a total: they cover the 692 consultation files tracked so far (61,195 submissions, mostly 2025–26), so an organization's real filing history is larger, not smaller.
Who they are
Among the 1252 companies & groups on this site, they rank #925 by legislative files engaged, a count of participation, not a measure of influence.
Declares membership of
- AMR Industry Alliance
Self-declared to the EU Transparency Register (snapshot 27 Oct 2026).
- Register category
- Companies & groups
- Registered as
- Centrient Pharmaceuticals International B.V.
- Head office
- Delft, Netherlands
- EU office
- Rotterdam
Self-declared to the EU Transparency Register (snapshot 27 Oct 2026); cost bands are floors, not audited totals. Reused under Commission Decision 2011/833/EU.
Track Centrient in PolicySpeak: request access →
Follow Centrient Pharmaceuticals
An email when this organization files on a consultation we publish. Free with a PolicySpeak website account.
Work at Centrient Pharmaceuticals? so we know who speaks for it.
Their record over time
Centrient Pharmaceuticals filed 1 position on 27 Oct 2026, across 1 of the 692 legislative files tracked here, attaching a full position paper 1 time.
What they argued
Looking for an argument rather than an organization? Search every submission for a phrase and see everyone who used it.
Put Centrient Pharmaceuticals next to another organization. Same files, same register facts, side by side. Compare →
Is this your organization?
Everything on this page comes from Centrient Pharmaceuticals’s own submissions to the European Commission. We have added nothing and interpreted nothing. If something is wrong or out of date, email info@policyspeak.com and we will correct it. If you are an individual named in a record, our privacy policy sets out your rights to correction, objection and removal.
Quotes are verbatim from submissions published by the European Commission, trimmed to their opening passage and never summarized by a model. Organizations only, never individuals. Reused under Commission Decision 2011/833/EU; the European Commission is not liable for this reuse.